ArticleCancer science2020

Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.

Yuji Otsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.